1h Free Analyst Time
The global anti-cd20 monoclonal antibodies (mabs) market is forecasted to grow by USD 15.71 billion during 2025-2030, accelerating at a CAGR of 11.4% during the forecast period. The report on the global anti-cd20 monoclonal antibodies (mabs) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expanding therapeutic indications beyond oncology into autoimmune disorders, increasing prevalence of hematological malignancies and neuro-inflammatory autoimmune diseases, expansion of biosimilar platforms and patient-centric subcutaneous delivery innovations.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global anti-cd20 monoclonal antibodies (mabs) market is segmented as below:
By Product
- Oncology
- Neurology
- Immunology
By Type
- First generation
- Second generation
- Third generation
By End-User
- Hospitals and clinics
- Academic and research institutions
- Contract research organizations
By Drug Class
- Rituximab
- Ofatumumab
- Obinutuzumab
- Ublituximab
- Others
By Route Of Administration
- Intravenous
- Subcutaneous
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global anti-cd20 monoclonal antibodies (mabs) market covers the following areas:
- Global anti-cd20 monoclonal antibodies (mabs) market sizing
- Global anti-cd20 monoclonal antibodies (mabs) market forecast
- Global anti-cd20 monoclonal antibodies (mabs) market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Anti-CD20 Monoclonal Antibodies (MABs) Market 2020 - 2024
- Historic Market Size - Data Table on Global Anti-CD20 Monoclonal Antibodies (MABs) Market 2020 - 2024 ($ million)
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Anti-CD20 Monoclonal Antibodies (MABs) Market
6.2 Impact of Geopolitical Conflicts on Global Anti-CD20 Monoclonal Antibodies (MABs) Market
6.2 Impact of Geopolitical Conflicts on Global Anti-CD20 Monoclonal Antibodies (MABs) Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Product
8.1 Market segments
- Chart on Product - Market share 2025-2030 (%)
- Data Table on Product - Market share 2025-2030 (%)
- Chart on Comparison by Product
- Data Table on Comparison by Product
- Chart on Oncology - Market size and forecast 2025-2030 ($ million)
- Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
- Chart on Oncology - Year-over-year growth 2025-2030 (%)
- Data Table on Oncology - Year-over-year growth 2025-2030 (%)
- Chart on Neurology - Market size and forecast 2025-2030 ($ million)
- Data Table on Neurology - Market size and forecast 2025-2030 ($ million)
- Chart on Neurology - Year-over-year growth 2025-2030 (%)
- Data Table on Neurology - Year-over-year growth 2025-2030 (%)
- Chart on Immunology - Market size and forecast 2025-2030 ($ million)
- Data Table on Immunology - Market size and forecast 2025-2030 ($ million)
- Chart on Immunology - Year-over-year growth 2025-2030 (%)
- Data Table on Immunology - Year-over-year growth 2025-2030 (%)
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Type
9.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on First generation - Market size and forecast 2025-2030 ($ million)
- Data Table on First generation - Market size and forecast 2025-2030 ($ million)
- Chart on First generation - Year-over-year growth 2025-2030 (%)
- Data Table on First generation - Year-over-year growth 2025-2030 (%)
- Chart on Second generation - Market size and forecast 2025-2030 ($ million)
- Data Table on Second generation - Market size and forecast 2025-2030 ($ million)
- Chart on Second generation - Year-over-year growth 2025-2030 (%)
- Data Table on Second generation - Year-over-year growth 2025-2030 (%)
- Chart on Third generation - Market size and forecast 2025-2030 ($ million)
- Data Table on Third generation - Market size and forecast 2025-2030 ($ million)
- Chart on Third generation - Year-over-year growth 2025-2030 (%)
- Data Table on Third generation - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by End-user
10.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Chart on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
- Data Table on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
- Chart on Academic and research institutions - Year-over-year growth 2025-2030 (%)
- Data Table on Academic and research institutions - Year-over-year growth 2025-2030 (%)
- Chart on Contract research organizations - Market size and forecast 2025-2030 ($ million)
- Data Table on Contract research organizations - Market size and forecast 2025-2030 ($ million)
- Chart on Contract research organizations - Year-over-year growth 2025-2030 (%)
- Data Table on Contract research organizations - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
11 Market Segmentation by Drug Class
11.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Rituximab - Market size and forecast 2025-2030 ($ million)
- Data Table on Rituximab - Market size and forecast 2025-2030 ($ million)
- Chart on Rituximab - Year-over-year growth 2025-2030 (%)
- Data Table on Rituximab - Year-over-year growth 2025-2030 (%)
- Chart on Ofatumumab - Market size and forecast 2025-2030 ($ million)
- Data Table on Ofatumumab - Market size and forecast 2025-2030 ($ million)
- Chart on Ofatumumab - Year-over-year growth 2025-2030 (%)
- Data Table on Ofatumumab - Year-over-year growth 2025-2030 (%)
- Chart on Obinutuzumab - Market size and forecast 2025-2030 ($ million)
- Data Table on Obinutuzumab - Market size and forecast 2025-2030 ($ million)
- Chart on Obinutuzumab - Year-over-year growth 2025-2030 (%)
- Data Table on Obinutuzumab - Year-over-year growth 2025-2030 (%)
- Chart on Ublituximab - Market size and forecast 2025-2030 ($ million)
- Data Table on Ublituximab - Market size and forecast 2025-2030 ($ million)
- Chart on Ublituximab - Year-over-year growth 2025-2030 (%)
- Data Table on Ublituximab - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
12 Market Segmentation by Route of Administration
12.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
- Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
- Chart on Intravenous - Year-over-year growth 2025-2030 (%)
- Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
- Chart on Subcutaneous - Market size and forecast 2025-2030 ($ million)
- Data Table on Subcutaneous - Market size and forecast 2025-2030 ($ million)
- Chart on Subcutaneous - Year-over-year growth 2025-2030 (%)
- Data Table on Subcutaneous - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
13 Customer Landscape
13.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
14 Geographic Landscape
14.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
15 Drivers, Challenges, and Opportunity
15.1 Market drivers
- Expanding therapeutic indications beyond oncology into autoimmune disorders
- Increasing prevalence of hematological malignancies and neuro-inflammatory autoimmune diseases
- Expansion of biosimilar platforms and patient-centric subcutaneous delivery innovations
- Biosimilar price erosion and commercial margin pressure
- Immunological safety risks and heightened regulatory scrutiny
- Complex bioprocessing requirements and cold chain vulnerabilities
- Impact of drivers and challenges in 2025 and 2030
- Emergence and rapid clinical integration of next-generation bispecific anti-CD20 constructs
- Transition toward high-concentration subcutaneous formulations and outpatient dosing systems
- Expansion of anti-CD20 monoclonal antibodies into autoimmune, neurological, and renal indications
16 Competitive Landscape
16.1 Overview
16.2 Competitive Landscape
16.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
17 Competitive Analysis
17.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- Biocon Ltd. - Overview
- Biocon Ltd. - Business segments
- Biocon Ltd. - Key offerings
- Biocon Ltd. - Segment focus
- SWOT
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Business segments
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- Gilead Sciences Inc. - Segment focus
- SWOT
- Hetero Labs Ltd. - Overview
- Hetero Labs Ltd. - Product / Service
- Hetero Labs Ltd. - Key offerings
- SWOT
- Innovent Biologics Inc. - Overview
- Innovent Biologics Inc. - Product / Service
- Innovent Biologics Inc. - Key news
- Innovent Biologics Inc. - Key offerings
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Sandoz Group AG - Overview
- Sandoz Group AG - Business segments
- Sandoz Group AG - Key news
- Sandoz Group AG - Key offerings
- Sandoz Group AG - Segment focus
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- TG Therapeutics Inc. - Overview
- TG Therapeutics Inc. - Product / Service
- TG Therapeutics Inc. - Key offerings
- SWOT
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
18 Appendix
18.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 9: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 10: Executive Summary - Chart on Incremental Growth
Exhibit 11: Executive Summary - Data Table on Incremental Growth
Exhibit 12: Executive Summary - Chart on Company Market Positioning
Exhibit 13: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 14: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 15: Chart on Overview on factors of disruption
Exhibit 16: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 17: Chart on Parent Market
Exhibit 18: Data Table on - Parent Market
Exhibit 19: Chart on Market characteristics analysis
Exhibit 20: Chart on Value chain analysis
Exhibit 21: Data Table on Offerings of companies included in the market definition
Exhibit 22: Market segments
Exhibit 23: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 25: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 27: Historic Market Size - Data Table on Global Anti-CD20 Monoclonal Antibodies (MABs) Market 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 33: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 34: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 35: Five forces analysis - Comparison between 2025 and 2030
Exhibit 36: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 37: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 39: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 40: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 41: Chart on Market condition - Five forces 2025 and 2030
Exhibit 42: Chart on Product - Market share 2025-2030 (%)
Exhibit 43: Data Table on Product - Market share 2025-2030 (%)
Exhibit 44: Chart on Comparison by Product
Exhibit 45: Data Table on Comparison by Product
Exhibit 46: Chart on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Neurology - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Neurology - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Immunology - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Immunology - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Immunology - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Immunology - Year-over-year growth 2025-2030 (%)
Exhibit 58: Market opportunity by Product ($ million)
Exhibit 59: Data Table on Market opportunity by Product ($ million)
Exhibit 60: Chart on Type - Market share 2025-2030 (%)
Exhibit 61: Data Table on Type - Market share 2025-2030 (%)
Exhibit 62: Chart on Comparison by Type
Exhibit 63: Data Table on Comparison by Type
Exhibit 64: Chart on First generation - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on First generation - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on First generation - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on First generation - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Second generation - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Second generation - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Second generation - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Second generation - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Third generation - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Third generation - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Third generation - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Third generation - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by Type ($ million)
Exhibit 77: Data Table on Market opportunity by Type ($ million)
Exhibit 78: Chart on End-user - Market share 2025-2030 (%)
Exhibit 79: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by End-user
Exhibit 81: Data Table on Comparison by End-user
Exhibit 82: Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Academic and research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Academic and research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Contract research organizations - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Contract research organizations - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Contract research organizations - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Contract research organizations - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by End-user ($ million)
Exhibit 95: Data Table on Market opportunity by End-user ($ million)
Exhibit 96: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 97: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 98: Chart on Comparison by Drug Class
Exhibit 99: Data Table on Comparison by Drug Class
Exhibit 100: Chart on Rituximab - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Data Table on Rituximab - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Chart on Rituximab - Year-over-year growth 2025-2030 (%)
Exhibit 103: Data Table on Rituximab - Year-over-year growth 2025-2030 (%)
Exhibit 104: Chart on Ofatumumab - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Data Table on Ofatumumab - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Chart on Ofatumumab - Year-over-year growth 2025-2030 (%)
Exhibit 107: Data Table on Ofatumumab - Year-over-year growth 2025-2030 (%)
Exhibit 108: Chart on Obinutuzumab - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Data Table on Obinutuzumab - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Chart on Obinutuzumab - Year-over-year growth 2025-2030 (%)
Exhibit 111: Data Table on Obinutuzumab - Year-over-year growth 2025-2030 (%)
Exhibit 112: Chart on Ublituximab - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Data Table on Ublituximab - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Chart on Ublituximab - Year-over-year growth 2025-2030 (%)
Exhibit 115: Data Table on Ublituximab - Year-over-year growth 2025-2030 (%)
Exhibit 116: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 119: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 120: Market opportunity by Drug Class ($ million)
Exhibit 121: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 122: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 123: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 124: Chart on Comparison by Route of Administration
Exhibit 125: Data Table on Comparison by Route of Administration
Exhibit 126: Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Chart on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 129: Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 130: Chart on Subcutaneous - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Data Table on Subcutaneous - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Chart on Subcutaneous - Year-over-year growth 2025-2030 (%)
Exhibit 133: Data Table on Subcutaneous - Year-over-year growth 2025-2030 (%)
Exhibit 134: Market opportunity by Route of Administration ($ million)
Exhibit 135: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 136: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 137: Chart on Market share by geography 2025-2030 (%)
Exhibit 138: Data Table on Market share by geography 2025-2030 (%)
Exhibit 139: Chart on Geographic comparison
Exhibit 140: Data Table on Geographic comparison
Exhibit 141: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - North America
Exhibit 146: Data Table on Regional Comparison - North America
Exhibit 147: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Regional Comparison - Europe
Exhibit 164: Data Table on Regional Comparison - Europe
Exhibit 165: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Regional Comparison - Asia
Exhibit 194: Data Table on Regional Comparison - Asia
Exhibit 195: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 208: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 209: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 212: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 213: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 214: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 215: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 216: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 217: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 218: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 219: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 220: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 221: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 222: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 223: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 224: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 225: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 242: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 243: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 244: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 245: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 246: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 247: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 248: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 249: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 250: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 251: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 252: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 253: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 254: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 255: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 256: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 257: Market opportunity by geography ($ million)
Exhibit 258: Data Tables on Market opportunity by geography ($ million)
Exhibit 259: Impact of drivers and challenges in 2025 and 2030
Exhibit 260: Overview on criticality of inputs and factors of differentiation
Exhibit 261: Overview on factors of disruption
Exhibit 262: Impact of key risks on business
Exhibit 263: Companies covered
Exhibit 264: Company ranking index
Exhibit 265: Matrix on companies position and classification
Exhibit 266: AbbVie Inc. - Overview
Exhibit 267: AbbVie Inc. - Business segments
Exhibit 268: AbbVie Inc. - Key news
Exhibit 269: AbbVie Inc. - Key offerings
Exhibit 270: AbbVie Inc. - Segment focus
Exhibit 271: SWOT
Exhibit 272: Amgen Inc. - Overview
Exhibit 273: Amgen Inc. - Product / Service
Exhibit 274: Amgen Inc. - Key news
Exhibit 275: Amgen Inc. - Key offerings
Exhibit 276: SWOT
Exhibit 277: Biocon Ltd. - Overview
Exhibit 278: Biocon Ltd. - Business segments
Exhibit 279: Biocon Ltd. - Key offerings
Exhibit 280: Biocon Ltd. - Segment focus
Exhibit 281: SWOT
Exhibit 282: Biogen Inc. - Overview
Exhibit 283: Biogen Inc. - Product / Service
Exhibit 284: Biogen Inc. - Key news
Exhibit 285: Biogen Inc. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 288: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 289: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 290: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 291: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 292: SWOT
Exhibit 293: F. Hoffmann La Roche Ltd. - Overview
Exhibit 294: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 295: F. Hoffmann La Roche Ltd. - Key news
Exhibit 296: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 297: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 298: SWOT
Exhibit 299: Gilead Sciences Inc. - Overview
Exhibit 300: Gilead Sciences Inc. - Business segments
Exhibit 301: Gilead Sciences Inc. - Key news
Exhibit 302: Gilead Sciences Inc. - Key offerings
Exhibit 303: Gilead Sciences Inc. - Segment focus
Exhibit 304: SWOT
Exhibit 305: Hetero Labs Ltd. - Overview
Exhibit 306: Hetero Labs Ltd. - Product / Service
Exhibit 307: Hetero Labs Ltd. - Key offerings
Exhibit 308: SWOT
Exhibit 309: Innovent Biologics Inc. - Overview
Exhibit 310: Innovent Biologics Inc. - Product / Service
Exhibit 311: Innovent Biologics Inc. - Key news
Exhibit 312: Innovent Biologics Inc. - Key offerings
Exhibit 313: SWOT
Exhibit 314: Novartis AG - Overview
Exhibit 315: Novartis AG - Business segments
Exhibit 316: Novartis AG - Key news
Exhibit 317: Novartis AG - Key offerings
Exhibit 318: Novartis AG - Segment focus
Exhibit 319: SWOT
Exhibit 320: Pfizer Inc. - Overview
Exhibit 321: Pfizer Inc. - Business segments
Exhibit 322: Pfizer Inc. - Key news
Exhibit 323: Pfizer Inc. - Key offerings
Exhibit 324: Pfizer Inc. - Segment focus
Exhibit 325: SWOT
Exhibit 326: Sandoz Group AG - Overview
Exhibit 327: Sandoz Group AG - Business segments
Exhibit 328: Sandoz Group AG - Key news
Exhibit 329: Sandoz Group AG - Key offerings
Exhibit 330: Sandoz Group AG - Segment focus
Exhibit 331: SWOT
Exhibit 332: Teva Pharmaceutical Ltd. - Overview
Exhibit 333: Teva Pharmaceutical Ltd. - Business segments
Exhibit 334: Teva Pharmaceutical Ltd. - Key news
Exhibit 335: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 336: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 337: SWOT
Exhibit 338: TG Therapeutics Inc. - Overview
Exhibit 339: TG Therapeutics Inc. - Product / Service
Exhibit 340: TG Therapeutics Inc. - Key offerings
Exhibit 341: SWOT
Exhibit 342: Zydus Lifesciences Ltd. - Overview
Exhibit 343: Zydus Lifesciences Ltd. - Business segments
Exhibit 344: Zydus Lifesciences Ltd. - Key news
Exhibit 345: Zydus Lifesciences Ltd. - Key offerings
Exhibit 346: Zydus Lifesciences Ltd. - Segment focus
Exhibit 347: SWOT
Exhibit 348: Inclusions checklist
Exhibit 349: Exclusions checklist
Exhibit 350: Currency conversion rates for US$
Exhibit 351: Research methodology
Exhibit 352: Information sources
Exhibit 353: Data validation
Exhibit 354: Validation techniques employed for market sizing
Exhibit 355: Data synthesis
Exhibit 356: 360 degree market analysis
Exhibit 357: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 9: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 10: Executive Summary - Chart on Incremental Growth
Exhibit 11: Executive Summary - Data Table on Incremental Growth
Exhibit 12: Executive Summary - Chart on Company Market Positioning
Exhibit 13: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 14: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 15: Chart on Overview on factors of disruption
Exhibit 16: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 17: Chart on Parent Market
Exhibit 18: Data Table on - Parent Market
Exhibit 19: Chart on Market characteristics analysis
Exhibit 20: Chart on Value chain analysis
Exhibit 21: Data Table on Offerings of companies included in the market definition
Exhibit 22: Market segments
Exhibit 23: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 25: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 27: Historic Market Size - Data Table on Global Anti-CD20 Monoclonal Antibodies (MABs) Market 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 33: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 34: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 35: Five forces analysis - Comparison between 2025 and 2030
Exhibit 36: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 37: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 39: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 40: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 41: Chart on Market condition - Five forces 2025 and 2030
Exhibit 42: Chart on Product - Market share 2025-2030 (%)
Exhibit 43: Data Table on Product - Market share 2025-2030 (%)
Exhibit 44: Chart on Comparison by Product
Exhibit 45: Data Table on Comparison by Product
Exhibit 46: Chart on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Neurology - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Neurology - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Neurology - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Immunology - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Immunology - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Immunology - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Immunology - Year-over-year growth 2025-2030 (%)
Exhibit 58: Market opportunity by Product ($ million)
Exhibit 59: Data Table on Market opportunity by Product ($ million)
Exhibit 60: Chart on Type - Market share 2025-2030 (%)
Exhibit 61: Data Table on Type - Market share 2025-2030 (%)
Exhibit 62: Chart on Comparison by Type
Exhibit 63: Data Table on Comparison by Type
Exhibit 64: Chart on First generation - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on First generation - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on First generation - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on First generation - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Second generation - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Second generation - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Second generation - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Second generation - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Third generation - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Third generation - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Third generation - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Third generation - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by Type ($ million)
Exhibit 77: Data Table on Market opportunity by Type ($ million)
Exhibit 78: Chart on End-user - Market share 2025-2030 (%)
Exhibit 79: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by End-user
Exhibit 81: Data Table on Comparison by End-user
Exhibit 82: Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Academic and research institutions - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Academic and research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Academic and research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Contract research organizations - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Contract research organizations - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Contract research organizations - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Contract research organizations - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by End-user ($ million)
Exhibit 95: Data Table on Market opportunity by End-user ($ million)
Exhibit 96: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 97: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 98: Chart on Comparison by Drug Class
Exhibit 99: Data Table on Comparison by Drug Class
Exhibit 100: Chart on Rituximab - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Data Table on Rituximab - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Chart on Rituximab - Year-over-year growth 2025-2030 (%)
Exhibit 103: Data Table on Rituximab - Year-over-year growth 2025-2030 (%)
Exhibit 104: Chart on Ofatumumab - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Data Table on Ofatumumab - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Chart on Ofatumumab - Year-over-year growth 2025-2030 (%)
Exhibit 107: Data Table on Ofatumumab - Year-over-year growth 2025-2030 (%)
Exhibit 108: Chart on Obinutuzumab - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Data Table on Obinutuzumab - Market size and forecast 2025-2030 ($ million)
Exhibit 110: Chart on Obinutuzumab - Year-over-year growth 2025-2030 (%)
Exhibit 111: Data Table on Obinutuzumab - Year-over-year growth 2025-2030 (%)
Exhibit 112: Chart on Ublituximab - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Data Table on Ublituximab - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Chart on Ublituximab - Year-over-year growth 2025-2030 (%)
Exhibit 115: Data Table on Ublituximab - Year-over-year growth 2025-2030 (%)
Exhibit 116: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 119: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 120: Market opportunity by Drug Class ($ million)
Exhibit 121: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 122: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 123: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 124: Chart on Comparison by Route of Administration
Exhibit 125: Data Table on Comparison by Route of Administration
Exhibit 126: Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Chart on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 129: Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 130: Chart on Subcutaneous - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Data Table on Subcutaneous - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Chart on Subcutaneous - Year-over-year growth 2025-2030 (%)
Exhibit 133: Data Table on Subcutaneous - Year-over-year growth 2025-2030 (%)
Exhibit 134: Market opportunity by Route of Administration ($ million)
Exhibit 135: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 136: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 137: Chart on Market share by geography 2025-2030 (%)
Exhibit 138: Data Table on Market share by geography 2025-2030 (%)
Exhibit 139: Chart on Geographic comparison
Exhibit 140: Data Table on Geographic comparison
Exhibit 141: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - North America
Exhibit 146: Data Table on Regional Comparison - North America
Exhibit 147: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Regional Comparison - Europe
Exhibit 164: Data Table on Regional Comparison - Europe
Exhibit 165: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Regional Comparison - Asia
Exhibit 194: Data Table on Regional Comparison - Asia
Exhibit 195: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 208: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 209: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 212: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 213: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 214: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 215: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 216: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 217: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 218: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 219: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 220: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 221: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 222: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 223: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 224: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 225: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 242: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 243: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 244: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 245: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 246: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 247: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 248: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 249: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 250: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 251: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 252: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 253: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 254: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 255: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 256: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 257: Market opportunity by geography ($ million)
Exhibit 258: Data Tables on Market opportunity by geography ($ million)
Exhibit 259: Impact of drivers and challenges in 2025 and 2030
Exhibit 260: Overview on criticality of inputs and factors of differentiation
Exhibit 261: Overview on factors of disruption
Exhibit 262: Impact of key risks on business
Exhibit 263: Companies covered
Exhibit 264: Company ranking index
Exhibit 265: Matrix on companies position and classification
Exhibit 266: AbbVie Inc. - Overview
Exhibit 267: AbbVie Inc. - Business segments
Exhibit 268: AbbVie Inc. - Key news
Exhibit 269: AbbVie Inc. - Key offerings
Exhibit 270: AbbVie Inc. - Segment focus
Exhibit 271: SWOT
Exhibit 272: Amgen Inc. - Overview
Exhibit 273: Amgen Inc. - Product / Service
Exhibit 274: Amgen Inc. - Key news
Exhibit 275: Amgen Inc. - Key offerings
Exhibit 276: SWOT
Exhibit 277: Biocon Ltd. - Overview
Exhibit 278: Biocon Ltd. - Business segments
Exhibit 279: Biocon Ltd. - Key offerings
Exhibit 280: Biocon Ltd. - Segment focus
Exhibit 281: SWOT
Exhibit 282: Biogen Inc. - Overview
Exhibit 283: Biogen Inc. - Product / Service
Exhibit 284: Biogen Inc. - Key news
Exhibit 285: Biogen Inc. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 288: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 289: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 290: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 291: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 292: SWOT
Exhibit 293: F. Hoffmann La Roche Ltd. - Overview
Exhibit 294: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 295: F. Hoffmann La Roche Ltd. - Key news
Exhibit 296: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 297: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 298: SWOT
Exhibit 299: Gilead Sciences Inc. - Overview
Exhibit 300: Gilead Sciences Inc. - Business segments
Exhibit 301: Gilead Sciences Inc. - Key news
Exhibit 302: Gilead Sciences Inc. - Key offerings
Exhibit 303: Gilead Sciences Inc. - Segment focus
Exhibit 304: SWOT
Exhibit 305: Hetero Labs Ltd. - Overview
Exhibit 306: Hetero Labs Ltd. - Product / Service
Exhibit 307: Hetero Labs Ltd. - Key offerings
Exhibit 308: SWOT
Exhibit 309: Innovent Biologics Inc. - Overview
Exhibit 310: Innovent Biologics Inc. - Product / Service
Exhibit 311: Innovent Biologics Inc. - Key news
Exhibit 312: Innovent Biologics Inc. - Key offerings
Exhibit 313: SWOT
Exhibit 314: Novartis AG - Overview
Exhibit 315: Novartis AG - Business segments
Exhibit 316: Novartis AG - Key news
Exhibit 317: Novartis AG - Key offerings
Exhibit 318: Novartis AG - Segment focus
Exhibit 319: SWOT
Exhibit 320: Pfizer Inc. - Overview
Exhibit 321: Pfizer Inc. - Business segments
Exhibit 322: Pfizer Inc. - Key news
Exhibit 323: Pfizer Inc. - Key offerings
Exhibit 324: Pfizer Inc. - Segment focus
Exhibit 325: SWOT
Exhibit 326: Sandoz Group AG - Overview
Exhibit 327: Sandoz Group AG - Business segments
Exhibit 328: Sandoz Group AG - Key news
Exhibit 329: Sandoz Group AG - Key offerings
Exhibit 330: Sandoz Group AG - Segment focus
Exhibit 331: SWOT
Exhibit 332: Teva Pharmaceutical Ltd. - Overview
Exhibit 333: Teva Pharmaceutical Ltd. - Business segments
Exhibit 334: Teva Pharmaceutical Ltd. - Key news
Exhibit 335: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 336: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 337: SWOT
Exhibit 338: TG Therapeutics Inc. - Overview
Exhibit 339: TG Therapeutics Inc. - Product / Service
Exhibit 340: TG Therapeutics Inc. - Key offerings
Exhibit 341: SWOT
Exhibit 342: Zydus Lifesciences Ltd. - Overview
Exhibit 343: Zydus Lifesciences Ltd. - Business segments
Exhibit 344: Zydus Lifesciences Ltd. - Key news
Exhibit 345: Zydus Lifesciences Ltd. - Key offerings
Exhibit 346: Zydus Lifesciences Ltd. - Segment focus
Exhibit 347: SWOT
Exhibit 348: Inclusions checklist
Exhibit 349: Exclusions checklist
Exhibit 350: Currency conversion rates for US$
Exhibit 351: Research methodology
Exhibit 352: Information sources
Exhibit 353: Data validation
Exhibit 354: Validation techniques employed for market sizing
Exhibit 355: Data synthesis
Exhibit 356: 360 degree market analysis
Exhibit 357: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Biocon Ltd.
- Biogen Inc.
- Dr. Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- Genmab AS
- Gilead Sciences Inc.
- Hetero Labs Ltd.
- Innovent Biologics Inc.
- Intas Pharmaceuticals Ltd.
- Mabxience Holding S.L.
- Novartis AG
- Pfizer Inc.
- Reliance Life Sciences Pvt. Ltd.
- Sandoz Group AG
- Shanghai Henlius Biotech Inc.
- Teva Pharmaceutical Ltd.
- TG Therapeutics Inc.
- Zydus Lifesciences Ltd.
